Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription

Wen Ling Wang, Yi Chao Lee, Wen Ming Yang, Wen Chang Chang, Ju Ming Wang

研究成果: 雜誌貢獻文章

32 引文 (Scopus)

摘要

CEBPB, one of the CEBP family members, is a crucial regulator of gene expression during innate immunity, inflammatory responses and adipogenesis. In this study, the EGF-induced increase of CEBPB mRNA is shown to be coincident with the decrease of COX-2 mRNA. We identified that all of the individual CEBPB isoforms, LAP1, LAP2 and LIP, attenuate EGF-induced COX-2 promoter activity. Although increased sumoylation of both LAP1 and LAP2 is observed during the lagging stage of EGF treatment, only the sumoylated LAP1, but not the sumoylated LAP2, is responsible for COX-2 gene repression. In addition, EGF treatment can regulate the nucleocytoplasmic redistribution of HDAC4 and SUMO1. We further demonstrated by loss-of- and gain-of-function approaches that HDAC4 can be a negative regulator while inactivating COX-2 transcription. The sumoylation mutant LAP1, LAP1K174A, exhibits an attenuated ability to interact with HDAC4, and increased COX-2 promoter activity. Furthermore, the in vivo DNA binding assay demonstrated that LAP1K174A and CEBPDK120A, sumoylation-defective CEBPD mutants, attenuate the binding of HDAC4 on the COX-2 promoter. In light of the above, our data suggest that the suCEBPD and suLAP1 are involved in the repression of COX-2 transcription through the recruitment of HDAC4.

原文英語
頁(從 - 到)6066-6079
頁數14
期刊Nucleic Acids Research
36
發行號19
DOIs
出版狀態已發佈 - 2008
對外發佈Yes

指紋

Sumoylation
Epidermal Growth Factor
Adipogenesis
Messenger RNA
Aptitude
Regulator Genes
Innate Immunity
Protein Isoforms
Gene Expression
DNA
Genes

ASJC Scopus subject areas

  • Genetics

引用此文

Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription. / Wang, Wen Ling; Lee, Yi Chao; Yang, Wen Ming; Chang, Wen Chang; Wang, Ju Ming.

於: Nucleic Acids Research, 卷 36, 編號 19, 2008, p. 6066-6079.

研究成果: 雜誌貢獻文章

Wang, Wen Ling ; Lee, Yi Chao ; Yang, Wen Ming ; Chang, Wen Chang ; Wang, Ju Ming. / Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription. 於: Nucleic Acids Research. 2008 ; 卷 36, 編號 19. 頁 6066-6079.
@article{314b5ca5382f412e8d7706b1d82f6fd6,
title = "Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription",
abstract = "CEBPB, one of the CEBP family members, is a crucial regulator of gene expression during innate immunity, inflammatory responses and adipogenesis. In this study, the EGF-induced increase of CEBPB mRNA is shown to be coincident with the decrease of COX-2 mRNA. We identified that all of the individual CEBPB isoforms, LAP1, LAP2 and LIP, attenuate EGF-induced COX-2 promoter activity. Although increased sumoylation of both LAP1 and LAP2 is observed during the lagging stage of EGF treatment, only the sumoylated LAP1, but not the sumoylated LAP2, is responsible for COX-2 gene repression. In addition, EGF treatment can regulate the nucleocytoplasmic redistribution of HDAC4 and SUMO1. We further demonstrated by loss-of- and gain-of-function approaches that HDAC4 can be a negative regulator while inactivating COX-2 transcription. The sumoylation mutant LAP1, LAP1K174A, exhibits an attenuated ability to interact with HDAC4, and increased COX-2 promoter activity. Furthermore, the in vivo DNA binding assay demonstrated that LAP1K174A and CEBPDK120A, sumoylation-defective CEBPD mutants, attenuate the binding of HDAC4 on the COX-2 promoter. In light of the above, our data suggest that the suCEBPD and suLAP1 are involved in the repression of COX-2 transcription through the recruitment of HDAC4.",
author = "Wang, {Wen Ling} and Lee, {Yi Chao} and Yang, {Wen Ming} and Chang, {Wen Chang} and Wang, {Ju Ming}",
year = "2008",
doi = "10.1093/nar/gkn607",
language = "English",
volume = "36",
pages = "6066--6079",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription

AU - Wang, Wen Ling

AU - Lee, Yi Chao

AU - Yang, Wen Ming

AU - Chang, Wen Chang

AU - Wang, Ju Ming

PY - 2008

Y1 - 2008

N2 - CEBPB, one of the CEBP family members, is a crucial regulator of gene expression during innate immunity, inflammatory responses and adipogenesis. In this study, the EGF-induced increase of CEBPB mRNA is shown to be coincident with the decrease of COX-2 mRNA. We identified that all of the individual CEBPB isoforms, LAP1, LAP2 and LIP, attenuate EGF-induced COX-2 promoter activity. Although increased sumoylation of both LAP1 and LAP2 is observed during the lagging stage of EGF treatment, only the sumoylated LAP1, but not the sumoylated LAP2, is responsible for COX-2 gene repression. In addition, EGF treatment can regulate the nucleocytoplasmic redistribution of HDAC4 and SUMO1. We further demonstrated by loss-of- and gain-of-function approaches that HDAC4 can be a negative regulator while inactivating COX-2 transcription. The sumoylation mutant LAP1, LAP1K174A, exhibits an attenuated ability to interact with HDAC4, and increased COX-2 promoter activity. Furthermore, the in vivo DNA binding assay demonstrated that LAP1K174A and CEBPDK120A, sumoylation-defective CEBPD mutants, attenuate the binding of HDAC4 on the COX-2 promoter. In light of the above, our data suggest that the suCEBPD and suLAP1 are involved in the repression of COX-2 transcription through the recruitment of HDAC4.

AB - CEBPB, one of the CEBP family members, is a crucial regulator of gene expression during innate immunity, inflammatory responses and adipogenesis. In this study, the EGF-induced increase of CEBPB mRNA is shown to be coincident with the decrease of COX-2 mRNA. We identified that all of the individual CEBPB isoforms, LAP1, LAP2 and LIP, attenuate EGF-induced COX-2 promoter activity. Although increased sumoylation of both LAP1 and LAP2 is observed during the lagging stage of EGF treatment, only the sumoylated LAP1, but not the sumoylated LAP2, is responsible for COX-2 gene repression. In addition, EGF treatment can regulate the nucleocytoplasmic redistribution of HDAC4 and SUMO1. We further demonstrated by loss-of- and gain-of-function approaches that HDAC4 can be a negative regulator while inactivating COX-2 transcription. The sumoylation mutant LAP1, LAP1K174A, exhibits an attenuated ability to interact with HDAC4, and increased COX-2 promoter activity. Furthermore, the in vivo DNA binding assay demonstrated that LAP1K174A and CEBPDK120A, sumoylation-defective CEBPD mutants, attenuate the binding of HDAC4 on the COX-2 promoter. In light of the above, our data suggest that the suCEBPD and suLAP1 are involved in the repression of COX-2 transcription through the recruitment of HDAC4.

UR - http://www.scopus.com/inward/record.url?scp=56049122672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56049122672&partnerID=8YFLogxK

U2 - 10.1093/nar/gkn607

DO - 10.1093/nar/gkn607

M3 - Article

C2 - 18820298

AN - SCOPUS:56049122672

VL - 36

SP - 6066

EP - 6079

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 19

ER -